Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib
Autor: | Tartarone, Alfredo, Lazzari, Chiara, Lerose, Rosa, Conteduca, Vincenza, Improta, Giuseppina, Zupa, Angela, Bulotta, Alessandra, Aieta, Michele, Gregorc, Vanesa |
---|---|
Zdroj: | In Lung Cancer September 2013 81(3):328-336 |
Databáze: | ScienceDirect |
Externí odkaz: |